| Serial Number | 79371135 |
| Word Mark | AXXINOVAR |
| Filing Date | Monday, August 22, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 30, 2024 |
| Registration Number | 7292506 |
| Registration Date | Tuesday, January 30, 2024 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, November 14, 2023 |
| Goods and Services | Medicinal and pharmaceutical preparations for use in the syndromic approach for treating pain, headache, fever, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory disease, obstetrical/gynecological conditions, cardiovascular disease, skin diseases, allergic reactions, musculo-skeletal and joint diseases, kidney and urological disorders, otolaryngological diseases, eye diseases, neurological system diseases, metabolic and endocrinological diseases, hematological diseases, malignant diseases, protozoal infections and conditions, sexually transmitted infections, HIV and other viral infections, nutritional disorders and poisoning; pharmaceutical preparations, namely, contraceptive preparations |
| Goods and Services | Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; providing advertising, marketing and promotional services for the pharmaceutical and medical products of others |
| Goods and Services | Scientific and medical research and development in the fields of medicines, diagnostic aids and radio-pharmaceuticals for the treatment of pain, headaches, fevers, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory conditions, obstetrical/gynecological conditions and contraception, cardiovascular conditions, skin diseases and allergic reactions, musculo-skeletal and joint conditions, kidney and urological disorders, otolaryngological diseases, eye conditions, neurological conditions, metabolic and endorcinological conditions, hematological conditions, trauma and injuries, malignant disease conditions, malaria, tuberculosis, leprosy, sexually transmitted infections, HIV and other viral infections and conditions, protozoa infections and conditions, poisoning; medical research laboratory services; providing medical and veterinary research information in relation to all of the above; providing medical and scientific research information in the field of pharmaceuticals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 13, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 13, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 13, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NOT AVAILABLE |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 01 - Individual |
| Address | IN |
| Party Name | NOT AVAILABLE |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 01 - Individual |
| Address | IN |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | IN |
| Event Date | Event Description |
| Thursday, June 8, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, June 13, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 13, 2023 | ASSIGNED TO EXAMINER |
| Friday, June 16, 2023 | NON-FINAL ACTION WRITTEN |
| Saturday, June 17, 2023 | APPLICATION FILING RECEIPT MAILED |
| Saturday, June 17, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, July 24, 2023 | REFUSAL PROCESSED BY MPU |
| Monday, July 24, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, August 15, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, October 5, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 5, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 5, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 6, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 25, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, October 25, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, October 25, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Monday, November 13, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, November 14, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 14, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 30, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 30, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, April 30, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, May 1, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, May 22, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, May 1, 2024 | FINAL DISPOSITION PROCESSED |